Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Wins Reversal Of $72M Talc Verdict, Signaling Whole New Ballgame

Executive Summary

What has seemed an endless queue of plaintiffs waiting to litigate claims against J&J in Missouri for alleged talc harm may begin thinning out following a June mistrial and now the reversal of an earlier $72m verdict against the company, both due to jurisdictional issues dictated by a recent Supreme Court ruling.

Advertisement

Related Content

J&J Talc Setback: Missouri Court Decision Keeps Out-Of-State Plaintiff Door Open
J&J’s Talc Winning Streak Continues With Calif. Mesothelioma Verdict
Colgate's Ups, Downs In Bicoastal Fight Against Talc Mesothelioma Suits
J&J May Have Just Received Lifeline Out Of St. Louis Talc Tort Morass
Not Just J&J’s Problem: The Evolving Talc Litigation Landscape
J&J Talc Suit Dismissals: Plaintiffs Lack Causation Thread For Proof Quilt
J&J Talc Verdict Spells Opportunity For Plaintiffs, Talc-Free Powder Market

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS121264

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel